Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Overview of attention for article published in New England Journal of Medicine, July 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 2 citations on 2 Wikipedia pages.

Linda-Gail Bekker MBChB, DTMH, DCH, FCP(SA) is a Professor of Medicine and Chief Operating Officer of the Desmond Tutu HIV Foundation.

Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS.

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.